Skip to content

Investing Cash Flow at other companies

Pfizer logo
PfizerPFE
$785M-76.0%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$3.58M-90.3%
CG Oncology logo
CG OncologyCGON
-$334.85M-79.3%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.53M+110%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$50.69M+272%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s investing cash flow?
Oric Pharmaceuticals, Inc. (ORIC) reported investing cash flow of -$17.98M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
Oric Pharmaceuticals, Inc.'s investing cash flow decreased by 180.1% year-over-year, from $22.45M to -$17.98M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.